- Home
- IMRX vs SABA Comparison
IMRX vs SABA Comparison
Compare IMRX & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- SABA
- Stock Information
- Founded
- IMRX 2008
- SABA 1988
- Country
- IMRX United States
- SABA United States
- Employees
- IMRX N/A
- SABA N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- IMRX Health Care
- SABA
- Exchange
- IMRX Nasdaq
- SABA Nasdaq
- Market Cap
- IMRX 232.9M
- SABA 257.3M
- IPO Year
- IMRX 2021
- SABA N/A
- Fundamental
- Price
- IMRX $8.07
- SABA $9.10
- Analyst Decision
- IMRX Strong Buy
- SABA
- Analyst Count
- IMRX 4
- SABA 0
- Target Price
- IMRX $13.75
- SABA N/A
- AVG Volume (30 Days)
- IMRX 1.3M
- SABA 290.0K
- Earning Date
- IMRX 11-12-2025
- SABA 01-01-0001
- Dividend Yield
- IMRX N/A
- SABA 12.91%
- EPS Growth
- IMRX N/A
- SABA N/A
- EPS
- IMRX N/A
- SABA N/A
- Revenue
- IMRX N/A
- SABA N/A
- Revenue This Year
- IMRX N/A
- SABA N/A
- Revenue Next Year
- IMRX N/A
- SABA N/A
- P/E Ratio
- IMRX N/A
- SABA N/A
- Revenue Growth
- IMRX N/A
- SABA N/A
- 52 Week Low
- IMRX $1.10
- SABA $3.64
- 52 Week High
- IMRX $9.37
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- IMRX 69.91
- SABA 40.11
- Support Level
- IMRX $7.82
- SABA $9.13
- Resistance Level
- IMRX $8.85
- SABA $9.23
- Average True Range (ATR)
- IMRX 0.75
- SABA 0.09
- MACD
- IMRX 0.19
- SABA -0.02
- Stochastic Oscillator
- IMRX 69.91
- SABA 3.70
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.